Drug Price Controls

The Issue

There is concern among the general public about the cost of pharmaceuticals. Consumer advocates have issued a number of studies raising alarms about the rising prices that have resulted in proposals to put in place artificial caps.

Our Position

We are concerned that there are those who struggle to pay for their medications. Price controls, however, will do little but hamper the future development of new and better pharmaceuticals. The free market attracts investors willing to take the risks needed for successful innovation. We believe better alternatives are targeted government and private programs that help low income individuals afford the medications they need.

« View all Federal Issues

About MassBio

MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.

Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.

image of rss iconLatest Updates